JCR pharmaceuticals in Japan paid Mesoblast 2.1 million for use of their IP in the TEMCELL product. I believe the figure has fallen because JCR had to shut down production or slow down production, to increase their production line because demand was so high. Once it's up and running with more capacity I think Royalties would go past 5 mill US per quarter. They were just over 3 mill prior to the shut/slowdown.
JCR pharmaceuticals in Japan paid Mesoblast 2.1 million for use...
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 72431 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 20225 | 5 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |